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Development of T helper (Th) 17 cells requires trans-
forming growth factor (TGF)-b and interleukin (IL)-6
and is independent of the Th1 pathway. Although
T cells that produce interferon (IFN)-g are a recog-
nized feature of Th17 cell responses, mice deficient
for STAT4andT-bet—twoprototypical Th1 transcrip-
tion factors—are protected from autoimmunity asso-
ciated with Th17 pathogenesis. To examine the fate
and pathogenic potential of Th17 cells and origin of
IFN-g-producing T cells that emerge during Th17
immunity, we developed IL-17F reporter mice that
identify cells committed to expression of IL-17F and
IL-17A. Th17 cells required TGF-b for sustained
expression of IL-17F and IL-17A. In the absence of
TGF-b, both IL-23 and IL-12 acted to suppress IL-17
and enhance IFN-g production in a STAT4- and
T-bet-dependentmanner, albeitwithdistinct efficien-
cies. These results support a model of late Th17
developmental plasticity with implications for auto-
immunity and host defense.
INTRODUCTION
Thelper 17 is a thirdmajorCD4+Tcell effector subset important in
host protection and autoinflammatory disorders (McGeachy and
Cua, 2008; Stockinger and Veldhoen, 2007; Weaver et al., 2007).
Th17cells are characterizedbyproductionof thecytokines, inter-
leukin (IL)-17A, and IL-17F. Although originally proposed as
a branch of the Th1 lineage (Bettelli and Kuchroo, 2005; McKen-
zie et al., 2006), IL-17-producing effectors are now thought to
develop independently of both Th1 and Th2 lineages (Harrington
et al., 2005; Park et al., 2005). Th17 cells differentiate from naive
CD4+ T cell precursors in response to transforming growth factor
(TGF)-band IL-6; the Th1 lineage-associated factors signal trans-
ducer and activator of transcription (STAT)1, T-bet, and STAT4,
as well as the Th2 factors STAT6 and GATA3, are dispensable
for Th17 differentiation (Bettelli et al., 2006; Harrington et al.,
2005; Mangan et al., 2006; Park et al., 2005; Veldhoen et al.,
2006). Th17 development is inhibited by the Th1 cytokine and
interferon (IFN)-g, as well other cytokines that activate STAT192 Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc.(e.g., type I interferons and IL-27), by the Th2 cytokine IL-4
(Batten et al., 2006; Harrington et al., 2005; Park et al., 2005;
Villarino et al., 2003) and is constrained by IL-2 signaling via
STAT5 (Laurence et al., 2007). TGF-b, which is required for
Th17 development, has suppressive effects on Th1 development
(Gorham et al., 1998), through inhibitory effects on STAT4 and
T-bet signaling, and also inhibits Th2 development (Gorelik
et al., 2000; Lin et al., 2005). STAT3 plays a central role in Th17
development, coupling early IL-6 signaling to induction of IL-21,
an autocrine factor implicated in the progression of Th17 devel-
opment (Harris et al., 2007; Korn et al., 2007; Mathur et al.,
2007; Nurieva et al., 2007; Yang et al., 2007; Zhou et al., 2007).
IL-21, also acting in part through STAT3 signaling, can induce
expression of the transcription factors RORgt and RORa, which
appear to be essential for Th17-lineage specification (Ivanov
et al., 2006; Yang et al., 2008).
Despite the developmental signals that distinguish Th17 and
Th1 differentiation, there are interesting parallels between the
two developmental programs. IL-23R is induced in developing
Th17 cells and IL-12Rb2 is induced in developing Th1 cells to
pair with the constitutively expressed IL-12Rb1 chain to confer
responsiveness to IL-23 and IL-12, respectively. The IL-12Rb1
chain binds a common subunit of the IL-23 and IL-12 hetero-
dimers—IL-12p40 (or IL-12b)—that pairs with IL-23p19 (or
IL-23a) or IL-12p35 (or IL-12a), respectively (Aggarwal et al.,
2003; Oppmann et al., 2000; Parham et al., 2002). Activation of
the IL-23 or IL-12 receptors drives late events downstream of
early Th17 or Th1 lineage commitment (Harrington et al., 2005;
Mangan et al., 2006). Whereas the IL-12 receptor potently acti-
vates STAT4 in Th1 cells, the IL-23 receptor predominantly acti-
vates STAT3, but also recruits some STAT4 (Mathur et al., 2007;
Oppmann et al., 2000; Parham et al., 2002; Yang et al., 2007).
The long-held association of autoimmune models such as
experimental autoimmune encephalomyelitis (EAE), collagen-
induced arthritis (CIA), and inflammatory bowel disease (IBD)
with Th1-mediated pathogenesis has been revised in view of
the requirement for IL-23, but not IL-12, for disease in these
models (Cua et al., 2003; Langrish et al., 2005; Murphy et al.,
2003). This has given rise to a new Th17-mediated pathogenesis
paradigm (McGeachy and Cua, 2008). However, early reports
that linked IL-23 to induction of IL-17 expression by memory
CD4+ T cells also demonstrated induction of IFN-g expression
(Oppmann et al., 2000), and IFN-g-producing T cells are typically
found in association with IL-17-producing T cells in the context
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whereas mice lacking key components of the Th1 pathway
(e.g., IL-12p35, IFN-g, IFNgR, IL-12Rb2, and STAT1) retain
susceptibility to autoimmunity (Becher et al., 2002; Bettelli
et al., 2004; Ferber et al., 1996; Gran et al., 2002; Willenborg
et al., 1996; Zhang et al., 2003), deficiency of STAT4 and T-bet
can preclude disease (Bettelli et al., 2004; Chitnis et al., 2001;
Neurath et al., 2002), suggesting either that STAT4 and T-bet
have important roles in both Th1 and Th17 inflammation or that
cooperation of Th1 and Th17 responses is necessary for immune
pathogenesis in certain settings.
Although IL-23 is dispensable for Th17 commitment (Mangan
et al., 2006; Veldhoen et al., 2006), its requirement for Th17-
associated immune protection or autoimmunity is undisputed,
and it is speculated to enhance and/or maintain the Th17 pheno-
type (Veldhoen et al., 2006; Yang et al., 2007; Zhou et al., 2007).
Indeed, Th17 cells differentiated by TGF-b and IL-6 in the
absence of IL-23 have been shown to have a protective rather
than pathogenic role in a model of EAE (McGeachy et al.,
2007), consistent with an essential role for IL-23 in Th17 effector
function. Nevertheless, the precise effects of IL-23 on Th17
lineage stability remain unclear (McGeachy and Cua, 2008;
Weaver et al., 2007).
To explore the role of IL-23 in late Th17 development, we have
examined the fate and phenotype of Th17 cells generated and
maintained over the long term under defined cytokine condi-
tions. Using an IL-17F reporter mouse to identify developing
Th17 cells committed to expression of both IL-17F and IL-17A,
we found that TGF-b was essential for maintenance of IL-17
expression, whereas IL-23 was not. Propagation of committed
Th17 precursors in the presence of IL-23 without TGF-b resulted
in progressive extinction of IL-17F and, to a lesser extent, IL-17A
and promoted the emergence of IFN-g-producing cells that
lacked IL-17 expression. Remarkably, Th17 cells maintained
over the long term by TGF-b demonstrated persistent respon-
siveness to IL-12 despite relatively low expression of IL-12Rb2.
Stimulation of Th17 cells with IL-12 induced a rapid, STAT4-
and T-bet-dependent transition marked by extinction of RORgt,
RORa, IL-17A, and IL-17F and an induction of a Th1-like gene-
expression signature. Th17-committed cells generated in the
presence or absence of IL-23 induced rapid development of
colitis when transferred into immunodeficient recipients and
showed transition of a subset of cells to IFN-g expression.
Blockade of IL-23 ablated development of colitis, but did not
prevent persistence of IL-17-expressing cells nor transition to
a subset of IFN-g producers, whereas blockade of IL-23 and
IL-12 ablated development of colitis and markedly diminished
persistence of transferred Th17 cells. These findings support
substantial developmental plasticity of the Th17 lineage and
identify a mechanism for latent Th1-like responsiveness of
Th17 cells that provides a basis for understanding the relation-
ship between Th17 and Th1 mediated immunity.
RESULTS
TGF-b Is Required for Maintenance of IL-17
Expression by Th17 Cells
Although IL-23 is required for optimal expression of IL-17 under
conditions of limiting TGF-b during Th17 development (Zhouet al., 2007), it is dispensable for Th17 commitment and its role
in late Th17 development remains incompletely defined. To
examine the possible requirement for IL-23 in maintenance of
the Th17 phenotype, we propagated Th17 cells generated in
the absence of IL-23 under defined cytokine conditions in vitro
(Figure 1). Th17 cells maintained in the continued presence of
exogenous TGF-b demonstrated an increase in the frequency
of IL-17A+ progeny that was comparable in the presence or
absence of exogenous IL-6 or IL-23. Neutralization of possible
endogenous IL-6 had no detectable effect on the maintenance
of IL-17 expression, consistent with its being nonessential for
late events in Th17 development sustained by IL-21 (Korn
et al., 2007; Nurieva et al., 2007; Zhou et al., 2007, and data
not shown). In all cultures maintained with TGF-b, a subset of
IL-17A+ cells coexpressed IFN-g, despite the absence of IL-12
and irrespective of the addition (or absence) of IL-23 or IL-6.
Notably, whereas the frequency of IL-17A+ cells decreased
under conditions of IL-23 stimulation in the absence of TGF-b,
the frequency of cells that expressed IFN-g, without coexpres-
sion of IL-17A, markedly increased.
Because a minor fraction of IFN-g+ cells was generated under
Th17-polarizing conditions in the absence of IL-12 and IL-23
(Figure 1A), we postulated that IL-23 might act on this small
subset as a source for outgrowth of IFN-g+ progeny under condi-
tions in which TGF-b was deficient. To address this, we used
naive CD4+ T cells from IFN-g reporter mice (IfngThy1.1/Thy1.1)
that permit specific depletion of IFN-g-producing cells via the
Thy1.1 reporter molecule (Harrington et al., 2008). Th17 cells
were polarized as before, except that the small fraction of IFN-g+
(Thy1.1+) cells was depleted prior to further propagation with
either TGF-b and IL-6 or IL-23 (Figure 1B). Similar to previous
results, the fraction of IFN-g-producing cells was significantly
increased by IL-23 stimulation in the absence of continued
TGF-b, whereas IL-17A-producing cells were comparably ampli-
fied in the presence of TGF-b—aswere the subset of IL-17A+IFN-
g+ cells. Collectively, these results suggest that TGF-b is a critical
factor for both differentiation and maintenance of IL-17-
producing effector cells; Th17 cells do not stably express IL-17A
in the absence of continuous TGF-b signaling. In contrast, IL-23
appears to be dispensable for both the induction and mainte-
nance of Th17 cells, but instead is associated with transition to
progeny that extinguishes IL-17 expression and enhances IFN-g
expression under conditions of lowor absent TGF-b. Thus, devel-
oping Th17 cells can give rise to ‘‘Th1-like’’ progeny in the
absence of ongoing TGF-b signaling. Importantly, the converse
is not true; Th1-polarized cells are resistant to transition to
a Th17 cytokine-expression pattern when propagated under
Th17 conditions (Figure S1 available online and Harrington
et al., 2005). Accordingly, Th17 cells appear to have greater plas-
ticity with respect to their cytokine expression during late stages
of development.
Th17 Cells Respond to IL-12 to Rapidly Extinguish IL-17
and Promote IFN-g Expression
Th17 cells upregulate IL-23R as part of their developmental
program to confer responsiveness to IL-23 (Harrington et al.,
2005; Mangan et al., 2006; Oppmann et al., 2000; Zhou et al.,
2007). In contrast, developing Th1 cells upregulate IL-12Rb2 to
confer IL-12 responsiveness, and it is thought that the reciprocalImmunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc. 93
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constitutively expressed IL-12Rb1, is central to differential devel-
opment of Th17 and Th1 cells, respectively (Harrington et al.,
2005;Mangan et al., 2006; Zhou et al., 2007). Given the observed
deviation of Th17 cells toward enhanced IFN-g expression in the
presence of IL-23, we examined the possible effect of IL-12 on
Th17 cells (Figure 2). Naive CD4+ T cells polarized with Th17-
inductive cytokines andantigen-presenting cells (APCs) deficient
in expression of IL-12 and IL-23 (Il12b/) were divided into frac-
tions that were maintained for one to three more cycles of stimu-
lation with addition of the indicated exogenous cytokines.
Consistent with previous results, TGF-bwas required tomaintain
high frequencies of IL-17-expressing cells. Even in the absence
of added cytokines, antigen stimulation alone (OVAp) induced
progressive decline in IL-17A expression and enhanced IFN-g
Figure 1. Requirement for TGF-b in the
Maintenance of IL-17 Expression by
Th17-Polarized Cells
(A) FACS-sorted naive CD4+ T cells from OT-II
TCR transgenic mice were cultured with irradiated
Il12b/ (IL-12p40-deficient) splenic feeder cells
and 5 mg/ml OVAp for 7 days under Th17-polar-
izing conditions (TGF-b, 5 ng/ml; IL-6, 20 ng/ml;
anti-IFN-g, 10 mg/ml; anti-IL-4, 10 mg/ml), then
stained intracellularly for IL-17A and IFN-g after
PMA/ionomycin activation for 5 hr in the presence
of monensin (1 culture; left panel). Cells were har-
vested and restimulated with irradiated Il12b/
splenic feeder cells in the presence of indicated
cytokine(s) at the same doses or, in the case of
IL-23 and IL-12, at 1 ng/ml, with anti-IFN-g, anti-
IL-4, and OVAp for an additional two rounds
(7 days each) and stained intracelluarly for
IL-17A and IFN-g after PMA-ionomycin activation
(post 3 culture; right panels).
(B) IfngThy1.1/Thy1.1 OT-II naive CD4+ T cells were
cultured with irradiated Il12b/ splenic feeder
cells under Th17-polarizing conditions for 6 days
and a fraction of the recovered cells were stained
intracellularly for IL-17A and IFN-g after PMA-
ionomycin activation (left panel). A second fraction
of recovered CD4+ T cells were activated for 5 hr
with OVAp and Il12b/ feeder cells, and Thy1.1+
(IFN-g+) cells were depleted by magnetic sorting.
Thy1.1 depletion was confirmed by surface stain-
ing for Thy1.1 (middle panel), and the isolated
Thy1.1- cells were cultured with Il12b/ feeder
cells and OVAp and either TGF-b plus IL-6 or
IL-23 in the presence of anti-IFNg plus anti-IL-4
for three additional rounds (right panels), then
stained intracellulary for IL-17A and IFN-g after
PMA-ionomycin activation. Numbers in each
quadrant indicate percentages of total CD4+
T cells. All data are representative of at least three
independent experiments.
expression in the absence of exogenous
TGF-b. IL-23 signaling in the absence
of TGF-b significantly and consistently
increased the frequency of IFN-g+ cells
and decreased IL-17A+ cells relative to
the absence of TGF-b alone.
Remarkably, a large majority of Th17 cells restimulated with
IL-12 in the absence of TGF-b produced IFN-g (72%) and IL-
17A expression was markedly extinguished, such that a small
minority of cells produced IL-17A (8%) after only a single round
of culture. With continued maintenance in IL-12, most cells
became IFN-g single-producers (85%) and IL-17A was nearly
completely extinguished (<1%). The addition of TGF-b blunted
the effect of IL-12, but there was progressive deviation of the
cytokine phenotype toward enrichment of IFN-g producers and
loss of IL-17 producers nonetheless, such that IFN-g expression
became dominant despite continued TGF-b availability. This was
in contrast to the maintenance of a Th17 phenotype by
combined addition of TGF-b and IL-23 and was observed
despite the neutralization of IFN-g. Thus, although Th17 cells
are characterized by their upregulation of IL-23R and relatively94 Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc.
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Th17 Developmental PlasticityFigure 2. Th17 Cells Respond to IL-12 to Rapidly Upregulate IFN-g and Extinguish IL-17
OT-II CD4+ T cells were cultured with irradiated Il12b/ splenic feeder cells under Th17-polarizing condition for 7 days (1 culture, top panel), and a fraction of
recovered T cells were restimulated and analyzed for intracellular IL-17A and IFN-g as in Figure 1. The remaining T cells were cultured again with irradiated
Il12b/ splenic feeder cells in the presence of indicated cytokine(s), anti-IFNg, anti-IL-4, and OVAp as in Figure 1 for 7 days (2 culture, middle panel), and
a fraction was reanalyzed for intracellular cytokine expression. The remaining recovered cells from secondary cultures were recultured under identical cytokine
conditions for a third and fourth round (3 and 4 cultures, bottom panel), then analyzed for intracellular IL-17A and IFN-g after PMA-ionomycin activation as
before. Numbers in quadrants indicate percentage of total CD4+ cells in each. Data are representative of at least three experiments.low IL-12Rb2, the latter is sufficient to confer marked, rapid
deviation of cytokine phenotype in response to IL-12 when
unopposed by TGF-b.
IFN-g-Producing Effectors Arise from IL-17-Producing
Precursors
In the foregoing experiments, an appreciable fraction of T cells
generated under Th17-polarizing conditions did not express
either IL-17A or IFN-g, thereby raising the possibility that cells
that developed into IFN-g producers might emerge from uncom-
mitted (IFN-gIL-17A) precursors. Furthermore, because Th17
cells can express IL-17A and IL-17F, we sought to examine the
relationship of IL-17F and IL-17A expression and the possibility
that cells that deviated to an IL-17AIFN-g+ phenotype might
retain expression of IL-17F. We therefore generated IL-17F
reporter mice in which the Thy1.1 gene was introduced via
gene targeting into the endogenous Il17f gene, immediately
distal to the stop codon in exon 3 and downstream of an internal
ribosome entry site (IRES); these mice are hereafter referred to
as Il17fThy1.1/Thy1.1 mice (Figure S2). In these mice, Thy1.1
reporter expression is regulated by the endogenous Il17f locus
and expression of the endogenous Il17f gene is not disrupted,thus providing a reporter model with high fidelity and a fully func-
tional Il17f gene that enables identification and isolation of IL-
17F+ cells. Importantly, the IL-17F reporter is expressed early
in Th17 development and by a greater number of Th17 polarized
cells than IL-17A (Figure S2 and data not shown); the large
majority of cells that express IL-17A are a subset of cells that
express IL-17F, thereby establishing that an appreciable fraction
of developing Th17 cells express only IL-17F, and validating IL-
17F as a preferable marker for identification of early committed
Th17 cells (Figure 3A and Figure S2).
To examine the fate of committed Th17 cells, we activated
naive CD4+ T cells from Il17fThy1.1/Thy1.1 mice with anti-CD3
and Il12b/ (IL12p40-deficient) splenocytes under Th17-polar-
izing conditions and isolated Thy1.1+ (IL-17F+) cells by magnetic
or FACS sorting (Figure 3B and Figure S3). Recovered IL-17F+
cells were restimulated under distinct cytokine conditions, and
expression of IL-17A, IL-17F (Thy1.1) and IFN-g was assessed
after secondary and quaternary cultures (Figures 3C and 3D
and Figure S3). In agreement with previous results, cells that
expressed IFN-g, without coexpression of IL-17A or IL-17F,
were found to emerge from IL-17F+ Th17 precursors in the pres-
ence of IL-12 or IL-23 and absence of TGF-b, with IL-12 deviatingImmunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc. 95
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(A) FACS-sorted naive CD4+ T cells from Il17fThy1.1/Thy1.1 reporter mice were cultured with irradiated Il12b/ splenic feeder cells under Th17-polarizing conditions
for 6 days as in Figure 1. A fraction of recovered cells were analyzed for expression of CD4, Thy1.1 (IL-17F), and intracellular cytokine IL-17A and IFN-g after
PMA-ionomycin stimulation for 5 hr in the presence of monensin. The flow-cytometric plots are gated on CD4+ cells.
(B) Cells from (A) were collected and Thy1.1+ (IL-17F+) cells isolated by magnetic sorting. The purity of sorted Thy1.1+ cells was confirmed by surface staining of
Thy1.1. Numbers in the histograms are the fraction of CD4+ T cells in the indicated gates.
(C and D) Thy1.1+ cells were restimulated with irradiated Il12b/ splenic feeder cells in the presence of indicated cytokine(s), anti-IFNg, anti-IL-4, and anti-CD3
as in Figure 1 for a second (C) and fourth round (D) and were stained for CD4, Thy1.1 (IL-17F), and intracellular IL-17A and IFN-g after PMA-ionomycin activation
for 5 hr. Numbers in each quadrant indicate the percentage of total CD4+ T cells. Data are representative of at least three independent experiments.96 Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc.
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estingly, aminor subset of cells that coexpressed IL-17A, IL-17F,
and IFN-g developed independently of a requirement for IL-12,
IL-23, or IFN-g signaling and were retained under conditions
of continuous TGF-b availability (Figure 3 and Figure S3; data
not shown). Notably, IL-17F and IL-17A became coordinately ex-
pressed after continued culture in TGF-b and were similarly ex-
tinguished by IL-12 and IL-23 signaling without TGF-b. In parallel
studies using immobilized anti-CD3 and anti-CD28 to examine
the effects of TGF-b, IL-12, and IL-23 on recovered IL-17F+ cells,
comparable effects were seen, indicating that the effects on
Th17-phenotype shifts are not dependent on indirect effects
on APCs (data not shown). Furthermore, the emergence of
distinct cytokine phenotypes from initial populations sorted for
expression of IL-17F was not due to the outgrowth of a minor
contaminating population of IL-17F cells because intentional
contamination of the starting Thy1.1+-sorted population with
a fraction of Thy1.1 cells did not substantially alter the observed
expression pattern (data not shown, and Figures 2 and 3).
Concordant with the functional effects of IL-12 on committed
Th17 cells, we found detectable expression of IL-12Rb2 mRNA
in Th17 cells isolated from IL-17F reporter mice, albeit signifi-
cantly reduced expression compared to that of Th1 cells (Fig-
ure S4). Importantly, the responsiveness of Th17 cells to IL-12
is not transient but is retained over the long term by Th17 cells
maintained in the presence of TGF-b, consistent with retention
of IL-12Rb2 expression despite the absence of prior IL-12 or
IL-23 signaling or expression of detectable T-bet (Figure S5 and
data not shown). Taken together, these data establish that fully
committed Th17 cells can convert to IFN-g-producing cells via
IL-12 and IL-23 signaling and that TGF-b maintains IL-17A and
IL-17F expression and opposes IL-12- and IL-23-driven Th17
transition to IL-17IFN-g+ progeny.
Gene-Expression Signature of IL-12-Driven, IFN-g-
Producing T Cells that Develop from Th17 Precursors
Although the Th17 subset was originally defined as a distinct
effector lineage on the basis of its development independently
of the Th1 and Th2 lineages (Harrington et al., 2005; Park et al.,
2005), the IFNg+IL-17 phenotype of Th17 progeny generated
by IL-12 and IL-23 signaling suggests shared features with clas-
sical Th1 cells. To further characterize this population and
develop molecular signatures with which to extend comparative
studies of IL-12- and IL-23-deviated Th17 cells and classical Th1
cells, we performed gene-expression profiling of Th17 and Th1
cells to identify differentially expressed genes. FACS-sorted
naive CD4+ T cells from IfngThy1.1/Thy1.1 reporter mice were acti-
vated on Il12b/APCs under Th1- or Th17-polarizing conditions
for 5 days, isolated and restimulated with PMA and ionomycin for
5 hr, and subsequently enriched for the IFN-g+ fraction (in Th1
cells) or depleted of the IFN-g+ fraction (in Th17 cells) by
Thy1.1-based magnetic sorting. The sorted Th1 and Th17 cells
were processed for microarray-based gene-expression anal-
yses, as were naive CD4+ T cells that had been identically
stimulated (Figure S6).
Genes in activated Th1 or Th17 cells that were increased at
least 4-fold relative to activated naive cell precursors were deter-
mined and compared with one another (Figure S6A). The tran-
scriptome of the Th17 population was quite distinct from that ofTh1 cells. Of 1246 genes upregulated in either or both Th17 and
Th1 cells, 674 were specifically elevated in Th17 cells and 336
were specifically elevated in Th1 cells. The remaining 236 genes
were significantly elevated in both subsets relative to naive
controls. Of the genes specifically upregulated in Th17 or Th1
cells, many showed marked expression differences between
the subsets, as indicated by heat-map analysis (Figure S6B).
We used RT-PCR analysis to validate a subset of the 100 genes
most differentially expressed between the populations and
examined selected genes for acute expression changes induced
in Thy1.1+ (IL-17F+) Th17 cells derived from Il17fThy1.1/Thy1.1mice
restimulated under distinct cytokine conditions (Figure 4).
Expression of mRNA encoding lineage-associated transcrip-
tion factors was remarkable for the rapid downregulation of the
Th17 factors Rorc and Rora, and reciprocal upregulation of
Th1 factor Tbx21 (T-bet) in committed Th17 cells stimulated by
IL-12 without TGF-b (Figure 4, upper panel). This correlated
well with corresponding downregulation of Il17a and Il17f, and
upregulation of Ifng. Comparable effects were observed for
IL-23 in cells polarized several rounds without TGF-b, consistent
with the more modest, progressive effects of IL-23 compared to
the rapid effects of IL-12 (Figure S7). Th1-specific cytocidal
factors, exemplified by Fasl and Gzma, demonstrated similarly
rapid IL-12-mediated induction in Th17 cells that was blunted
by TGF-b (Figure 4, lower panel), as did several other Th1-
specific granzyme family members (not shown). Notably,
mRNA encoding IL-21, an autocrine factor for Th17 development
(Korn et al., 2007; Nurieva et al., 2007; Zhou et al., 2007), was
acutely upregulated by IL-12 in the absence of TGF-b. In
contrast, the IL-10 family member Il22 was significantly
enhanced by IL-23 but suppressed by IL-12, and its induction
by IL-23 was blunted by TGF-b, as previously reported (Zheng
et al., 2007). Il24, which was found to be the most differentially
expressed by Th17 cells among IL-10 family members (Figure S6
and data not shown), was upregulated by IL-23 but suppressed
by IL-12 in the absence of TGF-b, analogous to Il22. Interest-
ingly, Ccr6, and its ligand, Ccl20, both lineage-specific markers
for Th17 cells, were similarly inhibited by IL-12 and IL-23,
whereas Ccr5, a Th1-specific chemokine receptor, was induced
by IL-12 and IL-23. Collectively, these data support a rapid
reprogramming of Th17 cells by IL-12, with induction of a number
of genes that are characteristic of classical Th1 cells, suggesting
that Th17 cells retain substantial developmental plasticity to
permit deviation toward a more Th1-like phenotype contingent
upon IL-12 signaling. Importantly, although IL-23 supported
IFN-g expression, it had effects on late Th17 development that
were distinct from those of IL-12 (e.g., IL-22 and IL-24 induction)
and that reflected unique features of IL-23-dependent program-
ming related to its indirect effects on epithelial cells (Zheng et al.,
2007; Zheng et al., 2008).
Conversion of Th17 Cells Is STAT4 and T-bet Dependent
STAT4 and T-bet are important factors in the IL-12-dependent
development of Th1 cells, but are dispensable for the develop-
ment of Th17 cells (Harrington et al., 2005; Park et al., 2005).
However, conversion of Th17 precursors to effectors with
features similar to Th1 cells by IL-12—a potent activator of
STAT4—implicated this factor in IL-12-dependent silencing of
IL-17A and IL-17F and upregulation of IFN-g. Because IL-23Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc. 97
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Th17 Developmental PlasticityFigure 4. Divergence of Transcriptomes of Th17 Progeny Restimulated under Different Cytokine Conditions
FACS-sorted naive CD4+ T cells from Il17fThy1.1/Thy1.1mice were cultured with irradiated Il12b/ splenic feeder cells under Th17-polarizing conditions for 6 days.
Cells were collected and Thy1.1+ (IL-17F+) cells were isolated by magnetic sorting as in Figure 3. Isolated Thy1.1+ cells were restimulated with anti-CD3 and anti-
CD28 in the presence of indicated cytokine(s) and processed for mRNA quantification of the indicated genes at 6 hr (Fasl and Gzma) or 18 hr after stimulation by
real-time PCR. All data were normalized to 18S RNA and are expressed as fold differences (log2) relative to anti-CD3- and anti-CD28-stimulated cells. Data are
representative of two or three experiments.also activates STAT4, albeit less potently than IL-12 (Mathur
et al., 2007; Oppmann et al., 2000), it was possible that STAT4
activation by IL-23 might also contribute to the phenotype shift
induced by IL-23. Given the important role of T-bet in Ifng gene
expression, we wished to test whether T-bet might also
contribute to the observed phenotype shift initiated by IL-12 or
IL-23 signaling.
Naive CD4+ T cells isolated from wild-type (WT), Stat4/, and
Tbx21/ (T-bet-deficient) mice were differentiated in vitro with
WT or Il12b/ (IL-12p40-deficient) APCs under Th17-polarizing
conditions. As shown in Figure 5A, T cell deficiency of STAT4 or
T-bet had no significant effect on the development of IL-17-98 Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc.producing Th17 cells, nor did the absence of IL-23 or IL-12, as
previously reported (Harrington et al., 2005; Mangan et al.,
2006). However, T cell deficiency of either STAT4 or T-bet signif-
icantly blunted IL-12-driven upregulation of IFN-g (Figure 5B).
Notably, whereas STAT4-deficient T cells demonstrated compa-
rable expression of IL-17A under all conditions of restimulation,
T-bet-deficient T cells showed a significant decrement in the
frequencies of IL-17A+ cells after restimulation with IL-12, sug-
gesting that the extinction of IL-17 expression is at least partially
dependent on STAT4 via a T-bet-independent mechanism
(Figure 5B, right panel). Thus, the complete transition of IL-12-
stimulated Th17 precursors is both STAT4 and T-bet dependent,
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Th17 Developmental PlasticityFigure 5. Transition of Th17 Precursors into IFN-g-Producing Cells Is Stat4 and T-bet Dependent
(A) CD4+ T cells from WT (BALB/c), Stat4/, or Tbx21/mice were cultured with either WT or Il12b/ splenic feeder cells and anti-CD3 under Th17-polarizing
conditions for 7 days, and then a fraction was analyzed for CD4 and intracellular IL-17A and IFN-g after PMA-ionomycin stimulation for 5 hr.
(B) Recovered CD4+ T cells were restimulated with either irradiated WT or Il12b/ splenic feeder cells in the presence of indicated cytokine(s), anti-IFNg,
anti-IL-4, and anti-CD3 for an additional 5 days and analyzed as in (A).
(C and D) Naive CD4+ T cells fromBALB or B6WT, BALB.Stat4/, or B6.Tbx21/micewere cultured as in (A) for one round, a fractionwas analyzed for CD4 and
intracellular cytokines (IL-17A and IFN-g) as in (A), and the remainder was recultured for three additional rounds under the indicated cytokine conditions as in (B).
After the third round of culture, recovered BALB.WT and BALB.Stat4/ CD4+ T cells ([C], left and right panels) or B6.WT and B6.Tbx21/ ([D], left and right
panels) were activated with PMA-ionomycin and analyzed for CD4 and intracellular IL-17A and IFN-g. Numbers in quadrants indicate percentages of total
CD4+ T cells in each. Data are representative of at least two independent experiments.Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc. 99
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Th17 Developmental PlasticityFigure 6. A Subset of Th17 Cells Extinguish IL-17 and Transition to Single-Positive IFN-g Cells in Transfer Model of Colitis
(A and B) FACS-sorted CD4+CD45RBhi T cells (4 3 105) or CD4+CD45RBlo (2 3 105) T cells isolated from pooled spleen and LNs of Il17fThy1.1/Thy1.1 mice were
transferred into congenicRag1/mice as indicated. Th17-polarized T cells were generated from naive Il17fThy1.1/Thy1.1CD4+ T cells with Il12b/ APCs and anti-
CD3 (2.5 mg/ml) as in Figure 1, in the absence (Th17  IL-23) or presence (Th17 + IL-23) of 10 ng/ml IL-23. Thy1.1 (IL-17F) and Thy1.1+ (IL-17F+) cells were
isolated by FACS sorting (see Figure S8), and 33 105 cells were transferred as indicated. As shown in (A), 8 weeks after transfer, mice were sacrificed and intes-
tinal tissues were collected for histological processing and analysis. Shown are representative sections of colon from indicated experimental groups; all magni-
fications represent 403. (B) shows the incidence and severity of colitis 4 (upper panel) or 8 (lower panel) weeks after transfer of the indicated cell populations. n
represents the number of recipients in each group.100 Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc.
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and IL-17 silencing are not the same.
Consistent with a role for STAT4 and T-bet in the transition of
Th17 precursors by IL-12, the IL-23-driven transition, although
less robust in comparison to that induced by IL-12, was similarly
STAT4 and T-bet dependent (Figures 5C and 5D). Accordingly,
after three rounds of IL-23-driven restimulation of Th17 precur-
sors, the frequencies of IFN-g+IL-17A cells were significantly
decreased in STAT4- and T-bet-deficient T cells compared to
WT controls. In contrast to STAT4-dependent effects of IL-12
on suppression of IL-17 expression, IL-23-driven effects on
IL-17 expression appeared more complex, perhaps reflecting
more modest STAT4 recruitment by IL-23 and/or its recruitment
of STAT3 and STAT1. Finally, it is notable that Th17 cells differ-
entiated in the absence of IL-12, IL-23, IFN-g, STAT4, or T-bet
retain a modest, but significant and reproducible, subset of cells
that coexpress IL-17A and IFN-g, implicating an alternative
pathway to IFN-g expression yet to be defined.
Th17 Precursors Give Rise to IFN-g-Expressing
Cells in a Transfer Model of Colitis
Although IL-17 and IFN-g production by individual CD4+ T cells
tend to be mutually exclusive, both phenotypes have typically
been found in autoimmune- and infectious-disease models
associated with Th17-mediated immunity. The foregoing
in vitro studies identified differential effects of TGF-b, IL-23,
and IL-12 on late-stage development of committed Th17 cells
and suggested that the IFN-g-producing T cells found in these
models might arise from Th17 precursors. To explore this possi-
bility, we examined the fate and disease-inducing potential
of committed Th17 precursors in a transfer model of colitis
(Figure 6). Naive CD4+ T cells from Il17fThy1.1/Thy1.1 mice were
polarized ex vivo under Th17 conditions, in the absence or pres-
ence of IL-23, then FACS sorted for Thy1.1 (IL-17F) expression
(Figure S8) and transferred into congenic, RAG-deficient recipi-
ents. CD4+ CD45RBhi and CD45RBlo fractions were also isolated
from Il17fThy1.1/Thy1.1 reporter mice and were cotransferred as
a negative control; alternatively, CD45RBhi cells were transferred
alone into RAG-deficient recipients as a positive control, for the
development of colitis (Powrie et al., 1994; Powrie et al., 1993).
Transfer of Th17-committed cells induced significant disease
that was comparable to that induced by CD45RBhi cells at
8 weeks after transfer, whether the Th17 population was gener-
ated in the absence or presence of IL-23 (Figures 6A and 6B).
Importantly, however, disease onset was considerably more
rapid in mice receiving IL-17F+ Th17 populations compared to
CD45RBhi controls (Figure 6B and Figure S9). The Th17 cells pre-
treated with IL-23 induced significantly higher disease scores
than Th17 cells not pretreatedwith IL-23 at 4 weeks after transfer
(p < 0.05), although this did not achieve statistical significance at
8 weeks. Notably, disease was also induced by transfer of Th17-
polarized cells sorted for lack of IL-17F expression, and although
the disease severity was significantly reduced at early timepoints, this pool of cells retained the capacity to develop into
pathogenic effectors.
Concordant with the onset of significant colitis histologically,
flow-cytometric analyses of T cells recovered from diseased
mice and activated ex vivo showed similar cytokine-expression
phenotypes, whether isolated from recipients of Thy1.1+ Th17
cells inducedwith orwithout IL-23or from recipients of CD45RBhi
cells (Figures 6C and 6D). Although essentially all transferred
Th17 cells initially expressed IL-17F (Thy1.1+) (Figure S8), there
was marked, progressive extinction of IL-17F relative to IL-17A
over the course of colitis development. Thus, although approxi-
mately half of the transferred cells expressed IL-17F alone (IL-17-
F+IL-17A-), and all IL-17A+ cells coexpressed IL-17F (IL-17F+IL-
17A+), few IL-17F+ cells were recovered, and the large majority
of IL-17F+ cells remaining were a subset of IL-17A+ cells. Further,
there was significant induction of IFN-g expression in transferred
T cells (Figures 6C and 6D), despite negligible or undetectable
IFN-g+ cells in the sorted fractions prior to transfer (Figure S8).
Neither the observed IL-17F extinction or IFN-g enhancement
appeared to be due to preferential enrichment of IL-17+ cells in
the inflamed intestines, given that T cells recovered from the
colons of diseased mice showed a similar cytokine phenotype
to those of themesenteric lymph nodes (MLNs) (data not shown).
Finally, the cytokine-phenotype shift observed in the transferred
T cells was not accompanied by expression of IL-10 because few
(<0.4%) of CD4+ T cells expressed detectable IL-10 prior to
transfer or after recovery (Figure S9 and data not shown). Thus,
as in vitro, committed Th17 cells can give rise to progeny that ex-
tinguished IL-17 expression and upregulated IFN-g expression,
although, interestingly, the majority of recovered cells
expressed neither. These results further establish that Th17 cells
inducedbyTGF-b and IL-6, either in the absence andpresenceof
IL-23, are colitogenic after transfer into immunodeficient recipi-
ents and give rise to a subset of IFN-g+ progeny that emerges
as a substantial component of the effector T cell response during
the development of immunopathology.
To determine whether IL-12 or IL-23 was required for the
phenotype shift observed in mice that received transfers of
committed Th17 precursors, we examined the effects of neutral-
izing antibodies to IL-23R or IL-12p40 on the development of
colitis and cytokine phenotype of transferred T cells generated
from Il17fThy1.1/Thy1.1 mice. Administration of either anti-IL-23R
or anti-IL-12p40 significantly ameliorated disease development
induced by transfers of sorted IL-17F+ Th17 populations 4weeks
after transfer (p < 0.01; Figure 7A), regardless of whether the
transferred T cells were pretreated with IL-23. Blockade of
IL-23 signaling resulted in a significant increase in ratio of
IFN-g- to IL-17A-producingTcells (Figure7B)becauseofahigher
fraction of IFN-g+ T cells (2-fold increase) among the CD4+
T cells recovered; there was no significant change in the fraction
of IL-17A+. However, the total numbers of CD4+ T cells numbers
were substantially reduced (>90%). Thus, absolute numbers of
IL-17+ and IFN-g+ cells were markedly reduced in the absence(C and D) IL-17A, Thy1.1 (IL-17F), and IFN-g expression of CD4+ T cells isolated from MLNs of indicated recipient mice 4 weeks (upper two panels) or 8 weeks
(lower panel) after cell transfer. Recovered cells were stimulated ex vivo with PMA-ionomycin and analyzed for CD4, Thy1.1, and intracellular IL-17A and IFN-g.
Numbers in each quadrant indicate percentages of total CD4+ T cells (C). Cumulative data for frequencies of cytokine-positive CD4+ T cells, as analyzed as in (C),
are shown in (D). Data are the means ± SEM for tissues and groups indicated. All data are representative of results from five similar experiments.Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc. 101
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Th17 Developmental PlasticityFigure 7. Effects of IL-23 and IL-12 Blockade on Th17 Precursors in Transfer Model of Colitis
(A) Th17-polarized T cells were generated from naive Il17fThy1.1/Thy1.1 CD4+ T cells with Il12b/ APCs and anti-CD3 (5 mg/ml) as in Figure 1, in the absence
(Th17 -IL-23) or presence (Th17 +IL-23) of 5 ng/ml IL-23. Thy1.1+ (IL-17F+) cells were isolated by FACS sorting and 33 105 cells were transferred into congenic
Rag1/mice as indicated. Recipients were administered 100 mg of anti-IL-23R, anti-IL-12p40, or isotype control via i.p. injection in saline 1 day prior and 1 day
after T cell transfers and once weekly thereafter (five total doses). Mice were sacrificed 4 weeks after transfer and analyzed histologically and scored for devel-
opment of colitis.
(B) Mice that received Th17 -IL-23 (IL-17F+) T cells and treated as in (A) were sacrificed 4 weeks after transfer, and cells recovered from MLNs were stimulated
ex vivo with PMA ionomycin and analyzed for CD4 and intracellular IL-17A and IFN-g by FACS. Data are the means from five mice in each treatment group.
*p < 0.05 and **p < 0.01 versus control treatment group. Data are representative of two similar experiments.of IL-23. Notably, anti-IL-12p40 administration caused an even
more profound loss of recoverable T cells, obviating assessment
of the effects on combined blockade of IL-23 and IL-12 signaling
on late-stage phenotype conversion and suggesting that survival
of transferred Th17 cells was not sustained in the absence of
IL-23 or IL-12 signaling.
DISCUSSION
A prominent feature of Th17 immunity induced in both infectious
and autoimmune settings is the development of a substantial
component of IFN-g-producing cells, some of which coexpress
IL-17, but a majority of which don’t. The recognition early that
IL-23 induction of IL-17 expression in the memory pool of CD4+
T cells was accompanied by low amounts of IFN-g expression
(Oppmann et al., 2000), together with the recognition that IL-23
and IL-12 shared the common IL-12p40 (IL-12b) subunit and their
receptors used the common IL-12Rb1 subunit, gave rise to spec-
ulation that IL-17-producing effectors developed as a late branch
of the Th1 lineage (Bettelli and Kuchroo, 2005; Mathur et al.,
2006; McKenzie et al., 2006). In this study, we provide evidence
that the opposite is true. Using IL-17F reporter mice for isolation
of committed IL-17-producing effectors, we found that Th17
precursors coexpressed IFN-g independently of IL-23 and IL-
12—or STAT4—signaling, but also responded to IL-23 and
IL-12 to give rise to progeny that shifted their phenotype toward102 Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc.enhanced IFN-g expression and IL-17A and IL-17F extinction,
contingent upon limited or absent TGF-b. Thus, Th17 cells
demonstrate substantial developmental plasticity after their
commitment to the Th17 program, and TGF-b appears to be
critical for the maintenance of IL-17 expression, at least in part
by opposing the STAT4-mediated effects of IL-23—and particu-
larly IL-12—to extinguish expression of IL-17F and IL-17A
and promote expression of IFN-g. A role for TGF-b in both the
induction and maintenance of IL-17A and IL-17F expression
draws a further parallel in shared functions for this cytokine in
the developmental programs of both Th17 and induced Treg cells
(Weaver et al., 2006).
Although differential expression of IL-23R and IL-12Rb2 has
been thought to distinguish Th17 and Th1 developmental
programs, we found that whereas IL-12Rb2 expression is
substantially diminished in Th17 cells, it remains fully functional.
Even after long-termmaintenance of Th17 cells in the absence of
IL-12 or IFN-g, there was rapid phenotype deviation in response
to IL-12, indicating mechanisms for induction and retention of IL-
12Rb2 that are not extinguished by TGF-b. TCR signaling alone
can induce low levels of IL-12Rb2 in human T cells in anticipation
of STAT4 signaling (Letimier et al., 2007), consistent with our
results and similarly to effects of IL-12 on human Th17 clones
(Annunziato et al., 2007). Thus, the balance of TGF-b and IL-12
or IL-23 controls the late-stage phenotype of Th17 cells. Activa-
tion of STAT4 by IL-12 and IL-23 was important for the induction
Immunity
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of IL-17 coexpression, and themore potent effects of IL-12 in the
induction of the IL-17 to IFN-g transition are consistent with
stronger activation of STAT4 by the IL-12 receptor (Oppmann
et al., 2000; Parham et al., 2002). Although STAT4 was essential
for IL-12-mediated suppression of IL-17A and IL-17F and for
IFN-g induction, the effects of T-bet induction appeared more
limited to the enhancement of IFN-g; deficiency of T-bet did
not preclude the suppression of IL-17 by IL-12 or IL-23, although
the reduced expression of T-bet induced by IL-23 in the absence
of TGF-b complicates this conclusion.
Importantly, although both IL-23 and IL-12 promoted
increased IFN-g expression and deviation from IL-17 expression
in Th17 precursors, the programs induced were not the same.
Both kinetics of deviation and transcriptomes of the cells induced
differed. Thus, despite the fact that both IL-12 and IL-23 showed
similarly rapid effects on the suppression of a number of ‘‘signa-
ture’’ Th17 factors (e.g., CCR6, CCL20, and AhR), the suppres-
sion of IL-17A and IL-17F and upregulation of T-bet and IFN-g
occurred within hours in response to IL-12, but required days in
response to IL-23. Furthermore, IL-23-induced effects were
more potently opposed by TGF-b signaling and IL-23 typically
failed to completely extinguish IL-17A. In support of previous
studies (Kolls and Linden, 2004; McGeachy et al., 2007; Zheng
et al., 2007), we found that IL-23 is unique in its promotion of
IL-22 expression; compared to IL-23, IL-12 and TGF-b both
markedly blunted induction of IL-22. Interestingly, chronic IL-23
signaling showed differential effects on Rorc and Rora expres-
sion; the former was suppressed in association with
upregulation of Tbx21, whereas Rora expression was retained.
The transcriptome of Th17 cells deviated by IL-12 signaling
was largely indistinguishable from classical Th1 cells. In the
absence of tempering TGF-b activity, IL-12 rapidly suppressed
the Th17 transcription factors Rorc and Rora, but upregulated
Tbx21, and promoted expression of the cytocidal factors Fasl
and multiple granzymes (e.g., Gzma) among other genes that
are highly expressed by conventional Th1 cells, but not Th17
cells. This extends the importance of IL-12 as a potent cytokine
for promoting an effector programwell adapted for eradication of
intracellular pathogens and implies that the ‘‘master regulators’’
of Th17 differentiation—RORgt and RORa (Ivanov et al., 2006;
Yang et al., 2008)—can be overridden by cell-extrinsic factors.
Prior to discovery of the Th17 lineage and a nonredundant role
for IL-23 in several models of autoimmunity, immune pathogen-
esis in thesemodelswasascribed todysregulatedTh1 responses
(reviewed by McGeachy and Cua, 2008; Weaver et al., 2007). A
simple Th1 correlation was complicated by the persistence of
disease development in studies using mice deficient for IFN-g,
IFN-gR, STAT1, or IL-12p35 (Becher et al., 2002; Bettelli et al.,
2004; Ferber et al., 1996; Gran et al., 2002; Willenborg et al.,
1996) andwas largely dispelledwith the discovery that mice defi-
cient for IL-23 (IL23a/), but not IL-12 (Il12a/), were resistant to
autoimmunity (Cua et al., 2003). Accordingly, T cell-transfer
studies demonstrated more potent disease induction by Th17
cells compared to Th1 cells (Elson et al., 2007; Langrish et al.,
2005), andsuccessful treatmentwithblockingantibodiesspecific
for IL-23established that Th17cellswere theprincipal effectors in
autoimmunepathogenesis in several diseasemodels (Chenet al.,
2006; Elson et al., 2007). Nevertheless,mice deficient in STAT4orT-bet, which are dispensable for Th17 development, are resistant
to autoimmunity in these models (Bettelli et al., 2004; Chitnis
et al., 2001; Neurath et al., 2002), suggesting that these signaling
factors might play a Th17-independent role. The findings herein
link STAT4 and T-bet to a late shift in the Th17 developmental
program, thereby offering an explanation for these results, and
may explain the observed predominance of Th17 cells early
and ‘‘Th1’’ cells late in the CNS in EAE (Dardalhon et al., 2008).
Although studies in additional autoinflammatory models will be
needed, our colitis studies establish that IFN-g cells can emerge
fromTh17precursors in the context of T cell-driven inflammation,
and although precise mechanisms remain to be established
because of the loss of Th17 cell survival in the absence of IL-23
and IL-12, we speculate that in the absence of STAT4 and T-
bet, aspects of the late events in Th17 development critical for
maintenance of ongoing inflammation are impaired. This is high-
lighted by the balance of IL-17A+IFN-g and IL-17AIFNg+ cells
in colitic mice and the lack of colitis development after adoptive
transfers of CD45RBhi T cells deficient in T-bet expression (Neu-
rath et al., 2002).
An important facet of our findings concerns the phenotype of
Th17 cells maintained in TGF-b. In contrast to a recent report
that demonstrated an IL-10-dependent protective effect of
Th17 cells induced with TGF-b and IL-6 in the absence of IL-23
(McGeachy et al., 2007), we found minimal induction of IL-10
expression in cells polarized with TGF-b and IL-6, even after
prolonged culture under these Th17-inducing conditions in the
absence of IL-23, and Th17 cells induced under these conditions
were pathogenic, not protective upon adoptive transfers.
Accordingly, the transfer of TGF-b-and-IL-6-polarized Th17 cells
derived from IL-17F reporter mice into immunodeficient hosts
induced colitis similarly to that of CD45RBhi transfers (Powrie
et al., 1996; Powrie et al., 1994), implying that the IL-10-associ-
ated regulatory function attributed to Th17 cells induced without
IL-23 may be model specific. Indeed, our finding that TGF-b is
a maintenance factor for IL-17A and IL-17F expression by Th17
cells might also contribute to the anticolitic effect of TGF-b
neutralization previously attributed to blockade of regulatory
cell function in the CD45RBhi model (Powrie et al., 1996).
However, CD45RBhi cells that are poorly responsive to TGF-b
by virtue of expression of a dominant-negative transgenic
TGF-b receptor (dnTbRII) induced colitis after adoptive transfers
intoRag1/mice (Izcue et al., 2008), albeit with reduced disease
severity. It is unclear whether this might be due to default Th1
development, which can also drive colitis (Iqbal et al., 2002),
whether TGF-b signaling in these cells remains adequate for
some TGF-b-dependent functions, or whether other factors are
involved. Additional studies to define the cytokine phenotypes
and the origins of colitiogenic T cells that emerge under condi-
tions of reduced TGF-b actions in this model will be needed to
resolve this.
A notable feature of Th17 biology revealed by the
Il17fThy1.1/Thy1.1 reporter mouse concerns the relative expression
patterns of IL-17A and IL-17F. IL-17F expression was dominant
early in Th17 development, such that a substantial fraction of
Th17 cells expressed IL-17F alone and themajority of IL-17A-ex-
pressing cells were a subset of the larger IL-17F pool, consistent
with early developmental predominance of IL-17F homodimer
(IL-17F-F) and IL-17A-F heterodimer expression and limitedImmunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc. 103
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Th17 Developmental PlasticityIL-17A homodimer expression (Liang et al., 2007). TGF-b
promoted the enhanced expression of both cytokines in vitro,
inducing progressive convergence of IL-17A and IL-17F expres-
sion; thus essentially all cells maintained coexpression of both
cytokines with continuing TGF-b stimulation. Interestingly, IL-23
restimulation in the absence of TGF-b appeared to induce more
pronounced extinction of IL-17F than IL-17A, resulting in a
predominance of IL-17A expression by cells that retained IL-17.
Given the higher binding affinity of IL-17A-A for the IL-17RA
receptor (Hymowitz et al., 2001), and its more potent proinflam-
matory effects compared to IL-17A-F or IL-17F-F in some
settings (Chang and Dong, 2007; Liang et al., 2007), this may
represent an important effect of IL-23 in promoting Th17 inflam-
mation and is consistent with the relative retention of IL-17A
compared to IL-17F in our colitis studies.
Why has the Th17 lineage evolved to enable a shift from domi-
nant IL-17 to dominant IFN-g expression? Given that the selec-
tive pressures shaping the emergence of the Th17 lineage have
been driven by pathogenic challenges, important evolutionary
benefit must be derived from this developmental transition.
Several evolutionary benefits are envisioned and are not mutu-
ally exclusive. First, given the potent tissue destructive capacity
of the ‘‘rapid response,’’ neutrophilic inflammation driven by
IL-17 cytokines, transition to a less tissue destructive, monocytic
pattern of inflammation promoted by IFN-g, i.e., transition from
an ‘‘acute’’ to ‘‘chronic’’ inflammation pattern, could represent
an evolutionary adaptation to limit tissue injury during late-stage
clearance of certain infectious agents. In this regard, IFN-g
inhibits Th17 development, and the transition to IFN-g produc-
tion might play a role in negative feedback on Th17 development
as a mechanism to regulate exaggerated IL-17 production while
retaining an active protective response. Alternatively, the IL-17-
to-IFN-g transition may represent a strategy by which the T cell
response can adapt to modulation of survival strategies em-
ployed by pathogens that can shift to an intracellular survival
mode to evade host mechanisms of extracellular eradication.
Association of Th17 responses with a number of extracellular
bacterial and fungal pathogens has been established, although
few pathogens induce T cell IL-17 responses without a corre-
sponding induction of IFN-g. Even pathogens that are depen-
dent upon IFN-g for host protection, such as Mycobacterium
tuberculosis, can elicit early IL-17 responses that transition to
IFN-g-dominated responses (Khader et al., 2007). Although this
has been attributed in part to a role for Th17 cells in recruiting Th1
cells in rechallenge responses, we propose that much of the
Th1 ‘‘recruitment’’ attributed to Th17 cells reflects transition of
primed Th17 effectors to IFN-g-producing progeny; the transi-
tion of antigen-specific, antipathogenic Th17 cells to IFN-g
producers with distinct functional properties might permit the
adaptive T cell response to efficiently coordinate pathogen clear-
ance in response to changing cytokine cues from innate immune
cells as the pathogen adapts to evade first-line host clearance
mechanisms. Finally, the enrichment of Th17 cells at host-envi-
ronment interfaces, particularly the intestines, in which there is
abundant TGF-b and an ongoing homeostatic response to the
commensal flora, may facilitate rapid responses to epithelial
barrier breach to accentuate clearance of extracellular organ-
isms while facilitating clearance of organisms ingested by newly
recruited myeloid cells that can produce IL-12 and shift the T cell104 Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc.response to enhance intracellular killing of ingested microbes. In
a sense then, Th17 cells represent the ultimate adaptive immune
cells, representing a ‘‘two-for-one’’ effector T cell lineage
capable of adjusting its effector program as needed to match
requirements for efficient orchestration of early and late
immune-clearance mechanisms and balancing a need to retain
antipathogen responses while curbing the host tissue destruc-
tion wrought by unchecked neutrophilic responses.
EXPERIMENTAL PROCEDURES
Mice
The following mice were purchased from the Jackson Laboratories and/or
bred at our facility: BALB/cByJ (BALB/c), C57BL/6J (B6), B6.OT-II TCR trans-
genic mice (OT-II), BALB/c.129S2-Stat4tm1Gru/J (STAT4-deficient), B6.129S6-
Tbx21tm1Glm/J (T-bet-deficient), B6.129S1-Il12btm/Jm/J (IL-12p40-deficient),
and B6 Rag1/. The generation of IFNg-Thy1.1 (IfngThy1.1/Thy1.1) reporter
mice was described previously (Harrington et al., 2008). BALB.Tbx21/
mice used in some studies were a kind gift from D. Bullard (UAB). All animals
were bred andmaintained in accordance with institutional animal care and use
committee regulations.
Generation of Il17fThy1.1/Thy1.1 Reporter Mice
The BAC clone RP24-305203, which contains the Il17f and Il17a genes, was
purchased from Children’s Hospital Oakland Research Institute (CHORI).
The Il17f gene and flanking sequence were retrieved from the BAC clone
into a pBluescript plasmid containing a TK cassette by recombineering-based
gap repair (Harrington et al., 2008). A targeting construct containing an EMCV
IRES element, Thy1.1 coding sequence, and LoxP-flanked neomycin resis-
tance cassette was flanked with miniarms of homology to exon 3 Il17f genomic
sequence and integrated between the Il17f stop codon and 30 untranslated
sequence (Figure S2), as previously described for similar targeting of the
Ifng gene (Harrington et al., 2008). The Il17F-Thy1.1 targeting construct was
linearized with NotI and electroporated into Bruce4 mouse embryonic stem
cells, as previously described (Harrington et al., 2008). Drug-resistant clones
were selected for homologous recombination by Southern-blot analysis and
microinjected into albino C57BL/6-blastocysts at the UAB Transgenic Mouse
Facility, and founder lines were established from chimeric mice as described
(Harrington et al., 2008 and see Figure S2).
CD4+ T Cell Preparation and Culture
CD4+ T cells were purified frompooled spleen and lymph nodes bymouseCD4
Dynabeads and thenDETACHaBEADmouseCD4+, according to themanufac-
turer’s directions (Invitrogen). NaiveCD4+T cellswere isolated by FACSsorting
for the CD25loCD62Lhi fraction. Unless otherwise indicated, naive CD4+ T cells
were cultured at a ratio of 1:5 with irradiated splenic feeder cells for 7 days in
RPMI containing 10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin,
1 mMsodium pyruvate, 13 non-essential amino acids, 2.5 mM b-mercaptoeha-
nol, and 2 mM L-glutamine (R-10). OT-II TCR transgenic CD4+ cells were
activated with 5 mg/ml OVA peptide (OVAp), whereas nontransgenic cells
were stimulated with 2.5 mg/ml anti-CD3 (clone 145-11), supplemented with
5 ng/ml rhTGF-b1 (R&D Systems), 20 ng/ml rmIL-6 (R&D Systems), 10 mg/ml
anti-IFN-g (clone XMG1.2), and 10 mg/ml anti-IL-4 (clone 11B11). In restimula-
tion cultures, viable T cells were recovered on day 7 of previous cultures and
activated with fresh splenocytes, cytokines, and antibody mixtures as indi-
cated. Unless otherwise indicated, rmIL-23 or rmIL-12 (R&D Systems) were
added at 1 ng/ml. Thy1.1+ cells of Il17fThy1.1/Thy1.1 or IfngThy1.1/Thy1.1 reporter
mice were isolated or depleted by magnetic sorting according to the manufac-
turer’s instructions (Miltenyi) or by FACS sorting, as indicated.
Flow-Cytometric Analyses
CD4+ T cells were collected and, where indicated, stimulated with PMA
(50 ng/ml; Sigma) and ionomycin (750 ng/ml; Calbiochem) for 5 hr in the pres-
ence of Golgi Plug (BD). Intracellular staining was performed as previously
described (Maynard et al., 2007). We used LIVE/DEAD Fixable Green Dead
Cell Stain (Invitrogen) to exclude dead cells in flow-cytometric analyses.
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Th17 Developmental PlasticityFluorescein isothiocyanate (FITC)-conjugated anti-IFN-g (XMG1.2), phycoery-
thrin (PE)-conjugated anti-CD90.1 (OX-7), anti-IL-17 (TC11-18H10), and peri-
dinin chlorophyll protein (PerCP)-conjugated anti-CD90.1 (OX-7) were
purchased from BD Biosciences; Alexa-Fluor-647-conjugated anti-IL-17A
(17B7), anti-IL-17F (18F10), allophycocyanin (APC)-conjugated anti-IL-10
(JES5-16S3), and PE-Cy7-conjugated anti-CD4 (GK1.5) were purchased
from eBioscience. Samples were acquired on an LSRII instrument (BD Biosci-
ences), and data were analyzed with CellQuest Pro (BD Biosciences) or
FlowJo software (Tree Star).
Gene-Expression Analyses
mRNA was extracted from T cells with TRIZOL (Invitrogen) and then treated
with DNA-free (Ambion). cDNA synthesis was performed with Superscript III
first-strand synthesis system (Invitogen). Real-time PCR was performed on
a Bio-Rad iCycler with primer pairs specific for cDNAs of Il12rb1, Il12rb2,
Il23r, Rorc, Rora, Tbx21, Il17a, Il17f, Ifng, Ccr6, Ccr20, Ccr5, Il22, Il24, Il21,
and Fasl andGzmamRNA transcripts with SYBRGreenER qPCR supermix (In-
vitrogen). The following primer sequences were used: IL-12Rb1, sense primer,
50-TACAGTTCAGGCGCCGGAT-30, antisense primer, 50-AGAGTTAACCTGA
GGTCCGCAG-30; IL-12Rb2, sense primer, 50-CCTCTTAACAGCACGTCCTG
G-30, antisense primer, 50-GGTCTCAGATCTCGCAGGTCA-30; IL-23R, sense
primer, 50-GCCAAGAAGACCATTCCCGA-30, antisense primer, 50-TCAGTGCT
ACAATCTTCTTCAGAGGACA-30; Rorgt, sense primer, 50-CAGCCAACATGTG
GAAAAGCT-30, antisense primer, 50-GGGAAGGCGGCTTGGA-30; Rora, sense
primer, 50-TGACGCCCACCTACAACATC-30, antisense primer, 50- CATCCATA
TAGGTGCTGAGGTCAT-30; IL-17A, sense primer, 50-TGAAGGCAGCAGCGA
TCA-30, antisense primer, 50-GGAAGTCCTTGGCCTCAGTGT-30; IL-17F,
sense primer, 50-CGCCATTCAGCAAGAAATCC-30, antisense primer, 50-CTCC
AACCTGAAGGAATTAGAACAG-30; IFN-g, sense primer, 50-ACAATGAACGCT
ACACACTGCAT-30, antisense primer, 50-TGGCAGTAACAGCCAGAAACA-30;
CCR6, sense primer, 50-CCTCTGTGCCCGGGTTTAC-30, antisense primer,
50-CATTATCATTTTCGACGGTCTCACT-30; CCL20, sense primer, 50-TCAACT
CCTGGAGCTGAGAATG-30, antisense primer, 50-CCATGCCAAAGCAAGGAA
GA-30; CCR5, sense primer, 50-GTTCCTGAAAGCGGCTGTAAA-30, antisense
primer, 50-GCAGTCAGGCACATCCATAGAC-30; IL-24, sense primer, 50-CTGT
GCAAACTCAGGATGACATC-30, antisense primer, 50-CGAGACATTCCGCAG
AACCT-30; FASL, sense primer, 50-GGCTGGGTGCCATGCA-30, antisense
primer, 50-GGCACTGCTGTCTACCCAGAA-30; Granzyme A, sense primer, 50-
GGGTGGGAGAGCCACGAT-30, antisenseprimer, 50-GAAGAAAAAGGAGAGT
AGCAAGAGATG-30; IL-22, sense primer, 50-TCCGAGGAG TCAGTGCTAA
A-30, antisense primer, 50-AGAACGTCTTCCAGGGTGAA-30; and IL-21, sense
primer, 50-AAGATTCCTGAGGATCCGAGAAG-30, antisense primer, 50-TGCAT
TCGTGAGCGTCTATAGTG-30. Reactionswere run in triplicate and normalized
to 18S rRNA.
Adoptive-Transfer Model of Colitis
FACS-sorted naive CD4+ T cells from Il17fThy1.1/Thy1.1 mice were cultured with
Il12b/ feeder cells under Th17-polarizing condition for 6 days, and viable
cells were recovered (Lympholyte; Cedarlane). Selection for Thy1.1 expressing
cells was performed by magnetic or FACS sorting, and isolated CD4+Thy1.1+
cells were washed and resuspended in PBS for adoptive transfer. A total of
3 3 105 Thy1.1+ cells were injected i.p. into age-matched B6.RAG1-deficient
recipients. For CD45RB transfer controls, CD4+ T cells from pooled spleen and
lymph nodes of Il17fThy1.1/Thy1.1 reporter mice were isolated as above, with Dy-
nal Beads, and the recovered CD4+ T cells were stained with APC-conjugated
anti-CD4 (RM4-5) and FITC-conjugated anti-CD45RB (16A) (BD Biosciences)
sorted into CD4+CD45RB+ and CD4+CD45RB fractions as previously
described (Maynard et al., 2007). Sorted cells were washed and resuspended
in PBS for adoptive transfers. B6.RAG1-deficient recipients were injected
intraperitoneally with 4.0 3 105 cells. For treatment studies, recipient mice
were injected i.p with 100 mg of anti-IL-23R (a gift from R. Kastelein, SP
Biopharma), anti-IL-12p40 (C17.8), or isotype control in saline 1 day before
and 1 day after T cell transfers and once weekly thereafter.
All recipient mice were monitored regularly for signs of disease, including
weight loss, hunched appearance, pilo-erection of the fur coat, and loose
stools. At 4 or 8 weeks after transfer, mice were sacrificed and spleen,
MLNs, and colon were recovered. Colons were cut longitudinally, and 2 cm
lengths of tissue were obtained from the proximal, middle, and distal portionsof the colon, fixed immediately in 10% formalin, and processed for histopath-
ological analyses (Maynard et al., 2007). Samples were coded and scored by
a pathologist in a blinded fashion as previously described (Maynard et al.,
2007). Expression of Thy1.1 (IL-17F) and intracellular IL-17A and IFN-g from
recovered T cells was assessed by flow-cytometric analysis as above, after
activation with PMA and ionomycin ex vivo.
Statistical Analysis
Statistical significance was calculated by unpaired Student’s t test,
Mann-Whitney U or ANOVA as appropriate, with Prism software (GraphPad).
All p values % 0.05 are considered significant and are referred to as such in
the text. Unless otherwise specified, all studies for which data are presented
are representative of at least two similar studies.
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Gene-expression data have been deposited in the NCBI Gene Expression
Omnibus with the accession number GSE 14026.
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Note Added in Proof
During revision of the current manuscript, an article by Lexberg et al. used a cy-
tometric IL-17A secretion assay to identify plasticity in Th17 cells similar to
findings in our study (Eur. J. Immunol. 38, 2654–2664, 2008). Their study
also identified resistance to phenotype deviation of IL-17A+ cells found in
the CD4+CD62Llo memory pool, suggesting that mechanisms exist, as yet
undefined, for stabilizing the cytokine phenotype of at least a subset of
IL-17A+ cells.Immunity 30, 92–107, January 16, 2009 ª2009 Elsevier Inc. 107
